CRISPR Startup Inscripta Raises $55.5m Series C to Democratize Gene-Editing
Inscripta is building a business based on selling gene-editing tools, such as instruments, reagents, and software, and in order to create a market for these tools, the company is giving away CRISPR enzymes for free.
Sponsored
Restoring the soil quickly is key to capturing returns in regenerative agriculture